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Abstract: A flexible route to piperidine-2,4-diones variously substituted at the 6-, 5,6- and 
2,6-positions, both with and without 1-substitution, is described; no N-protective group is 
required. A related regioselective Dieckmann cyclisation is also described that uses Davies’ 
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1. Introduction 
     The piperidine ring, a privileged scaffold in pharmaceutically active compounds,1 is 
exemplified in the numerous piperidine alkaloids.2,3 Oxygenated forms of the piperidine ring 
such as substituted piperidin-2-ones are also present in a number of alkaloids3 and in other 
biologically active derivatives,4 and can confer advantages of increased stability and 
crystallinity compared with piperidine analogues. Diversely substituted piperidines and 
oxygenated piperidines find much use in drug development, but their synthesis is still 
challenging;5 general, scaleable methods are in demand. Many oxopiperidines including 
piperidine-2,4-diones possess biological  and pharmaceutical relevance (Fig. 1),6,7 some being 
key intermediates in the synthesis of kinase inhibitors6f and modulators of glutamate 
receptors6g but routes to 6-substituted piperidine-2,4-diones are limited.8 Enantiocontrolled 
strategies to substituted piperidines present a further challenge, although the work of Comins9 
and Davis10 has addressed some of the limitations in the range or location of substituents. 
Enantioselective syntheses of 1-unsubstituted piperidine-2,4-diones include rearrangements of 
substituted 1,3-oxazinan-2-ones,8 and cyclisations of N-sulfinyl δ-amino-β-keto esters,10 δ-
aryl-δ-amino-β-keto esters6d and N-Boc-β-amino acids.11 Herein, we describe the synthesis of 
variously substituted piperidine-2,4-diones prepared via a regioselective Dieckmann 
cyclisation, some being obtained enantioselectively. 
         Corresponding author’s e-mail address: c.m.marson@ucl.ac.uk (C. M. Marson) 
 2 
N
H
O
O
Adalinine3b
O
N
H
O
O
Anti-hypoglycaemic agent6c
OMe
OMe
N
H
O
Aminoglutethimide,
aromatase inhibitor7b
O
NH2
NO
OH
Subunit of kirromycin antibiotics7a
O
R2
R1
N
R
O
!1d Adrenergic receptor antagonists
7c
O
 
Figure 1. Representative oxopiperidine derivatives with biological or pharmaceutical activity. 
 
2. Results and Discussion 
     It was desired to investigate the scope of Dieckmann cyclisations for the synthesis of 
piperidine-2,4-diones in regard to substituent location, and in particular to achieve a succinct 
protocol for the preparation of N-unsubstituted piperidine-2,4-diones, since few such 
Dieckmann cyclisations have been described, and  a cyclisation in THF that afforded 3-
methoxycarbonyl-6-(2-phenethyl)piperidine-2,4-dione in 15% yield.12 The proposed route 
(Scheme 1) began with β-keto esters 1, which in the cases of 1b and 1c were prepared by 
Weiler alkylation13 of the dianion of methyl acetoacetate (1a), prepared in THF using NaH (1.1 
equiv.) and butyllithium (1.1 equiv.), and reacted with methyl iodide or ethyl bromide, 
respectively (Scheme 2). Subsequent alkylation at the β-position was also possible, ester 1b 
being converted into 1d. Reaction of β-keto esters 1 with ammonium acetate in the presence of 
acetic acid afforded the vinylogous carbamates 2 which were reduced with sodium 
triacetoxyborohydride prepared in situ14 to give the corresponding β-amino esters 3. The latter 
were coupled with monomethyl malonate using EDC in the presence of HOBt to give the 
amidodiesters 4. Those underwent Dieckmann cyclisation upon treatment with sodium 
methoxide in methanol to give the keto esters 5 which were hydrolysed (NaOMe in methanol) 
and decarboxylated using sodium methoxide in wet acetonitrile6b in a one-pot process to give 
the corresponding piperidine-2,4-diones 6.  
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Scheme 1. Synthesis of substituted piperidine-2,4-diones and derivatives via Dieckmann cyclisations. 
Reagents and conditions: (a) NH4OAc, AcOH, PhH, reflux, 18-72 h; (b) NaBH4 (2.5 equiv.) AcOH, 20 
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°C, 3 h; (c) monomethyl malonate, EDC (1 equiv.), HOBt (1.5 equiv.), (i-Pr)2NEt, CH2Cl2, 20 °C, 2 h; 
(d) NaOMe (2 equiv.), MeOH, reflux, 1 h; (e) MeCN, 1% H2O, reflux, 1 h. 
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Scheme 2. Synthesis of β-keto esters via Weiler dialkylation. Reagents and conditions: (a) NaH (1.1 
equiv.), BuLi (1.1 equiv.), THF, MeI or EtBr  (1.1equiv.) EtOH, 20 °C, 3 h, 97% (1b), 85%, (1c); (b) 
MeI (1.0 equiv.), K2CO3 (1.5 equiv.), Me2CO, 0 °C, 2 h, 88% (1d). 
 
     For the 2,3-disubstitued β-amino esters 3, a Blaise reaction15 (Scheme 3) with in situ 
reduction was investigated, and afforded 6e; however, the poor yield suggested that the 
reductive amination of β-keto esters 1, as in Scheme 1, would in general be preferable. 
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Scheme 3. Synthesis of 2,3-disubstituted piperidine-2,4-diones. Reagents and conditions: (a) Zn (4 
equiv.), TMSCl (12 equiv.), CH2Cl2, THF, reflux, 2 h then NaBH4 (0.55 mole equiv.) EtOH, 20 °C, 3 h, 
15%; (b) monomethyl malonate, EDC (1.0 equiv.), HOBt (1.5 equiv.), (i-Pr)2NEt, CH2Cl2, 20 °C, 2 h, 
67%; (c) NaOMe (1.3 equiv.), MeOH, reflux, 1 h, then MeCN, 1% H2O, reflux, 1 h, 56%. 
 
     These results show that a variety of 6-monosubstituted piperidine-2,4-diones can be 
prepared by the protocol of Scheme 1, and that in all of the examples studied cyclisation 
proceeded satisfactorily and usually in good yields. 5,6-Disubstituted piperidine-2,4-diones can 
also be prepared, although not with high diastereoselectivity in the examples studied herein. 
Alkylation of 6f with MeI (3 equiv.) in acetone at 50 °C in the presence of potassium carbonate 
afforded the 3,3,6-trisubstituted piperidine-2,4-dione 6h (65%); no monomethyl product could 
be isolated, even when 1 equiv. of MeI was used. Accordingly, monomethylation of ester 5f 
was attempted using the conditions above, but no 6i was observed; however, using Page’s 
procedure16 alkylation with MeI (2 equiv.) in THF at 20 °C was achieved, affording 6i in 64% 
yield. Attempts to remove the methoxycarbonyl group from 6i, including sodium chloride in 
DMSO,17 LiI in pyridine, wet acetonitrile, or hydrochloric acid (1.3 M), all at reflux, were not 
successful. 
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Figure 2. Synthesis of substituted piperidine-2,4-diones and derivatives via Dieckmann cyclisations. 
 
     The scope of the 2-substituent appears to include 3-pyridyl, since the formation of 6g 
(Scheme 4) was confirmed by 1H NMR spectroscopy, but the aqueous solubility of this 
piperidine-2,4-dione precluded isolation under the standard procedures attempted.  
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Scheme 4. Attempted cyclisation of diester 4g. Reagents and conditions: (a) ClOCCH2CO2Me (1.5 
equiv.), (i-Pr)2NEt (4 equiv.), 0 °C, then 20 °C, 1 h, 99%; (b) NaOMe (1.3 equiv.), MeOH, reflux, 1 h, 
then MeCN, 1% H2O, reflux, 1 h. 
 
     The present study has established a greater scope of Dieckmann cyclisations that afford 
substituted piperidine-2,4-diones (Fig. 2), notably N-unsubstituted compounds; the use of 
dimethyl ester precursors, cyclised in methanol (in the presence of sodium methoxide), 
followed by decarbomethoxylation in aqueous acetonitrile appears to be an improved procedure 
for obtaining such Dieckmann products; for example, using those procedures, cyclisation and 
decarbomethoxylation afforded 6-phenylpiperidine-2,4-dione (6f) in 66% yield, compared with 
32% using previous conditions.6b Convenient features of this synthetic approach include the 
ready preparation of a wide variety of β-amino esters from the corresponding β-keto esters, and 
the avoidance of N-protection followed by N-deprotection; the substituted piperidine-2,4-diones 
are obtained directly as N-unsubstituted compounds, as are all intermediates. The route is 
compatible with one or more substituents at the 3-, 5- and 6-positions. 
     An enantioselective route to substituted piperidine-2,4-diones based on the regioselective 
Dieckmann cyclisation was then investigated (Scheme 5). The enantiomerically pure β-keto 
esters 8 were prepared by metalation of 7 and reaction with α,β-unsaturated esters, according to 
the Davies methodology.18 Deallylation of allylamines 8 was achieved using Wilkinson’s 
catalyst18b,19 via isomerisation to the corresponding enamides that are hydrolysed in situ.20 
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However, in the case of 8g several products were obtained; accordingly, allylic transfer was 
investigated, and was achieved using 1,3-dimethylbarbituric acid (3 equiv.) with a catalytic 
quantity of (Ph3P)4Pd in dichloromethane, affording 9g in 96% yield. Acylation of β-amino 
esters 9 using monomethyl malonate and EDC or, where that proved unsatisfactory, methyl 
malonyl chloride and Et3N afforded the corresponding malonamides 10 which underwent ring 
closure upon treatment with sodium methoxide in ethanol; in two cases the intermediate 
sodium salts 11 were isolated, but since those were only needed to confirm the course of the 
reaction, direct ester hydrolysis and decarboxylation was otherwise achieved, either using 
warm dilute hydrochloric acid at reflux or in wet acetonitrile at reflux, affording the 
enantiopure 6-piperidine-2,4-diones 12 in a one-pot procedure from diesters 10. Using 
methanesulfonic acid (0.9 equiv.) in toluene at reflux,21 several of the N-alkylated products 12 
were cleaved to the corresponding enantiopure piperidine-2,4-diones 6 lacking a 1-substituent 
(Fig. 3). 3,3-Dimethylation of 6l with methyl iodide (3 equiv.) in methanol in the presence of 
potassium carbonate afforded the 3,3,6-trisubstituted piperidine-2,4-dione 13. The route can 
also be used to prepare enantiomerically pure 4-hydroxypiperidinones, as illustrated by the 
reduction of (R)-6f to 14 using zinc borohydride.22 The 3-pyridyl derivative 12f could be a 
useful building block for the enantioselective synthesis of novel substituted piperidines related 
to the alkaloid anabasine. 
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Scheme 5. Enantioselective synthesis of substituted piperidine-2,4-diones and derivatives via 
Dieckmann cyclisations (R = (S)-1-phenylethyl). Reagents and conditions: (a) BuLi (1 equiv.), THF, -
78 °C, 30 min; RCH=CHCO2Me (1 equiv.), -78 °C, 30 min; (b) (Ph3P)3RhCl (5 mol%), aq. MeCN, 
reflux, 16 h; (c) methyl 3-chloro-3-oxopropanoate (1.1 equiv.), Et3N (1.2 equiv.), 0 °C to 20 °C, 1 h; 
(d) NaOMe (1.1 equiv.), reflux 1 h, then dil. HCl; (e) 1% water in MeCN, reflux 1 h; (f) MsOH (0.9 
equiv.), toluene, reflux, 3 h. 
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Figure 3. Enantioselective synthesis of substituted piperidine-2,4-diones and derivatives via 
Dieckmann cyclisations (R = (S)-1-phenylethyl). 
 
     This study shows that a variety of substituted piperidine-2,4-diones, in which 1-substitution 
may be present or absent, can be conveniently prepared by Dieckmann cyclisation. Use of the 
Davies18 conjugate addition of (S)-N-(α-methylbenzyl)allylamine (7) to α,β-unsaturated esters 
afforded enantiopure β-amino esters that also underwent Dieckmann cyclisation to give, after 
hydrolysis and decarboxylation, the corresponding substituted piperidine-2,4-diones; the chiral 
auxiliary was cleaved using methanesulfonic acid, thereby achieving some enantioselective 
syntheses of substituted piperidine-2,4-diones without 1-substitution. Synthesis of substituted 
piperidine-2,4-diones can be used to access to a variety of congeners of alkaloids or other 
pharmacologically active compounds, including 4-hydroxypiperidin-2-ones, the corresponding 
substituted piperidin-2-ones and piperidines; examples herein include the piperidine-2,4-dione 
12g, an analogue of anabasine, and (4R,6R)-4-hydroxy-6-phenylpiperidin-2-one (14) prepared 
by reduction of 6f with LiAlH4. 
 
3. Experimental Section 
3.1 General. All moisture-sensitive reactions were performed under a nitrogen atmosphere and 
the glassware was pre-dried in an oven (130 °C). Evaporation refers to the removal of solvent 
under reduced pressure. Melting points were measured by a microscope hot-stage 
Electrothermal 9100 apparatus. Infra-red (IR) spectra were recorded on a Perkin-Elmer PE-983 
spectrophotometer; absorptions are quoted in wavenumbers. 1H NMR spectra were recorded on 
a Bruker AC300 (300 MHz) spectrometer or a Bruker AMX 500 (125 MHz) spectrometer; data 
are reported in parts per million (δ). Coupling constants (J) are given in Hertz (Hz). The 
following abbreviations were used in signal assignments: singlet (s), broad singlet (br s), 
doublet (d), triplet (t), quartet (q), and multiplet (m). 13C NMR spectra were recorded on a 
Bruker AC300 (300 MHz) spectrometer or a Bruker AMX 500 (125 MHz) spectrometer; data 
are reported in parts per million (d), with CHCl3 as an internal standard. Mass spectra were 
recorded on a VG7070H mass spectrometer with Finigan Incos II data system at University 
College London. Optical rotations were measured using a Perkin-Elmer 343 digital polarimeter. 
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Thin-layer chromatography was performed on Merck 0.2 mm aluminium-backed silica gel 60 
F254 plates and visualised by UV (254 nm) or by staining with potassium permanganate with 
subsequent heating. Flash column chromatography was performed using Merck 0.040-0.063 
mm, 230-400 mesh silica gel. Temperatures below 0 °C were obtained using various mixtures 
of water, salt and ice, or acetone and dry ice. 
The following compounds were prepared according to the literature: methyl 2-methyl-3-
oxopentanoate (1d);23 methyl 3-amino-3-phenylpropanoate hydrochloride (3f);24 methyl 3-(2-
methoxycarbonylacetylamino)-3-phenylpropanoate (4f);25 (S)-N-(α-methylbenzyl)allylamine 
(7);26 (E)-methyl 4-methylpent-2-enoate;27 (E,E)-methyl hexa-2,4-dienoate;28 methyl (2E)-3-
cyclohexyl-2-propenoate;29 (E)-methyl 3-(pyridin-3-yl)propenoate.30 
General procedure A. Preparation of amidodiesters 4 and 10. Anhydrous 1-
hydroxybenzotriazole (1.5 equiv.) and N,N-diisopropylethylamine (4.0 equiv.) were added to 
a stirred solution of the β-amino ester 3 (1.0 equiv.) in dichloromethane at 0 °C, under 
nitrogen. Monomethyl malonate (3.0 equiv.) in dichloromethane was added dropwise; N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (1.0 equiv.) was added and the 
mixture was then allowed to warm to 20 °C and stirred for 2 h. Saturated aqueous sodium 
hydrogen carbonate was then added and the aqueous layer was extracted with ethyl acetate 
and the combined organic layers were washed with brine, dried (MgSO4) and evaporated. The 
residue was purified as described under the given product. 
General procedure B. Preparation of amido diesters 4. Triethylamine (1.3 equiv.) and 
methyl 3-chloro-3-oxopropanoate (1.2 equiv.) were added to a stirred solution of the β-amino 
ester 3 (1 equiv.) in dichloromethane at 0 °C, under nitrogen. The mixture was then allowed 
to warm to 20 °C and stirred for 1 h. The mixture was diluted with dichloromethane and 
washed with saturated aqueous sodium hydrogen carbonate. The aqueous layer was extracted 
twice with dichloromethane and the combined organic layers were dried (MgSO4) and 
evaporated. The residue was purified as described under the given product. 
General procedure C for Dieckmann cyclisations. Sodium methoxide (1.2 equiv.) in 
methanol was added to a stirred solution of the diester (1.0 equiv.) in methanol at 20 °C under 
nitrogen. The mixture was then heated under reflux for 1 h. After allowing to cool to 20 °C, 
the mixture was acidified with hydrochloric acid (1M) to pH 6. The aqueous layer was 
extracted with dichloromethane, dried (MgSO4), and evaporated. A solution of 1% water in 
acetonitrile was added to the oily residue, and the mixture was heated under reflux for 1 h. 
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The mixture was allowed to cool, then evaporated, and the residue was purified as described 
under the given product. 
General procedure D for Michael addition.18 n-Butyllithium (1.55 equiv.) in THF was 
added dropwise via a syringe to a stirred solution of (S)-N-(α-methylbenzyl)allylamine (7) 
(1.6 equiv.) in anhydrous THF at -78 °C under nitrogen. The mixture was stirred at -78 °C for 
a further 30 min. A solution of the α,β-unsaturated ester (1.0 equiv.) in anhydrous THF was 
added dropwise via syringe at -78 °C and the mixture was stirred for further 3 h at the same 
temperature. The mixture was then quenched with aqueous saturated ammonium chloride and 
allowed to warm to 20 °C over about 15 min. Evaporation gave a pale yellow liquid that was 
partitioned between dichloromethane and aqueous 10% citric acid. The aqueous layer was 
extracted with dichloromethane (3 x 10 mL) and all of the organic layers were combined, 
washed with saturated aqueous sodium hydrogen carbonate then brine, dried (MgSO4), and 
evaporated. The residue was purified as described under the given product. 
General procedure E for N-deallylation.18b,19 Tris(triphenylphosphine)rhodium(I) chloride 
(Wilkinson’s catalyst, 5 mol%) was added in one portion to a stirred solution of the β-amino 
ester (1.0 equiv.) in acetonitrile-water (85:15) at 20 °C. The mixture was then heated under 
reflux for 16 h. After allowing to cool, the mixture was extracted with dichloromethane, and 
the combined organic layers were dried (MgSO4) and evaporated. The residue was purified as 
described under the given product. 
Methyl 3-amino-2-methylpent-2-enoate (2d). Ammonium acetate (2.60 g, 33.8 mmol) and 
acetic acid (0.1 mL) were added to a stirred solution of methyl 2-methyl-3-oxopentanoate 
(1d) (0.98 g, 6.77 mmol) in benzene (50 mL). The mixture was heated under reflux for 72 h 
with the azeotropic removal of water. After allowing to cool to 20 °C, ethyl acetate (50 mL) 
was added and the mixture was washed with saturated aqueous sodium hydrogen carbonate 
(15 mL), dried (Na2SO4), and evaporated to give 2d (0.51 g, 52%) as an orange oil; IR νmax 
3303, 2924, 1744, 1656, 1610, 1462, 1161 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.72 (3H, s) 
2.25 (2H, q, J= 7.6 Hz) 1.75 (3H, s) 1.15 (3H, t, J= 7.6 Hz); m/z (CI, %) 144 ([M+H]+, 65). 
HRMS C7H14NO2 calcd. 144.1025, found 144.1019. 
Methyl 3-aminohexanoate (3c). Ammonium acetate (30.0 g, 0.39 mol) and acetic acid (0.1 
mL) were added to a stirred solution of methyl 3-oxohexanoate (1c) (11.2 g, 77.7 mmol) in 
benzene (160 mL). The mixture was heated under reflux for 72 h with the azeotropic removal 
of water. After allowing to cool to 20 °C, the mixture was diluted with ethyl acetate (150 
mL), washed with saturated aqueous sodium hydrogen carbonate (15 mL), dried (Na2SO4), 
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and evaporated to give the crude β-enamino ester as an oil. Sodium borohydride (7.15 g, 0.19 
mmol) was added in portions to a stirred solution of glacial acetic acid (200 mL) maintaining 
the temperature at near 20 °C. The mixture was stirred for 30 min until there was no more 
hydrogen was evolved. The β-enamino ester was then added in one portion and the mixture 
was stirred at 20 °C for 3 h. The acetic acid was removed under reduced pressure and the 
residue was dissolved in ethyl acetate (100 mL). The mixture was extracted with water (4 x 
100 mL), and the pH of the combined aqueous layers was adjusted to pH 12 by potassium 
carbonate. The solution was extracted with chloroform (3 x 150 mL) and the combined 
organic layers were dried (MgSO4), and evaporated to give 3c (3.61 g, 32%) as an orange oil; 
IR νmax 3272, 2957, 1736, 1553, 1436, 1379, 1174 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.73 
(3H, s) 3.18 (1H, m) 2.46 (1H, dd, J= 15.7, 4.0 Hz) 2.25 (1H, dd, J= 15.7, 9.0 Hz) 2.03 (2H, 
br s) 1.36-1.33 (4H, m) 0.91 (3H, t, J= 2.5 Hz); 13C NMR (300 MHz, CDCl3) δ 173.1, 51.5, 
48.0, 42.3, 39.7, 19.2, 14.0; m/z (CI, %) 146 ([M+H]+, 100). HRMS C7H16NO2 calcd. 
146.1181, found 146.1183. 
Methyl 3-amino-2-methylpentanoate (3d). Sodium borohydride (0.64 g, 16.8 mmol) was 
added in small portions to a stirred solution of glacial acetic acid (11 mL), maintaining the 
temperature near 20 °C. The mixture was then stirred for 30 min until no more hydrogen was 
evolved. Ester 2d (0.93 g, 6.47 mmol) was then added in one portion and the mixture was 
stirred at 20 °C for 3 h. The acetic acid was removed under reduced pressure and the residue 
was dissolved in ethyl acetate (10 mL). The solution was extracted with water (4 x 10 mL), 
and the pH of the combined aqueous layers was adjusted to pH 12 using potassium carbonate. 
The aqueous mixture was extracted with chloroform (3 x 15 mL) and the combined organic 
layers were dried (MgSO4), and evaporated to give 3d (0.63 g, 67%) as an orange oil, IR νmax 
(cm-1) 3321, 2961, 1731, 1569 cm-1; 1H NMR (500 MHz, CDCl3) (mixture of 
diastereoisomers) δ 3.67 (3H, s) 2.90-2.43 (2H, m) 1.53 (2H, br s) 1.42-1.16 (2H, m) 1.14-
1.11 (3H, m) 0.96-0.90 (3H, m). m/z (CI, %) 146 ([M+H]+, 100). HRMS C7H16NO2 calcd. 
146.1181, found 146.1179. 
Methyl 3-amino-2-methyl-4-phenylbutanoate (3e). Trimethylsilyl chloride (0.26 mL, 2.0 
mmol) was added to a stirred mixture of zinc dust (2.60 g, 39.3 mmol) in dichloromethane (13 
mL) at 20 °C under nitrogen, and the mixture was stirred for 30 min. Tetrahydrofuran (8 mL) 
was then added and the mixture was heated to 42 °C. A mixture of benzyl cyanide (1.00 g, 
8.54 mmol) and methyl 2-bromopropanoate (2.85 g, 17.1 mmol) was added and the reaction 
mixture was then heated under reflux for 2 h. After allowing to cool the mixture was filtered, 
and sodium borohydride (0.60 g, 15.4 mmol) and ethanol (2.5 mL) were added cautiously to 
the filtrate. The mixture was stirred for 3 h, then hydrochloric acid (2M, 9 mL) was then 
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added and the aqueous layer was extracted with dichloromethane (2 x 10 mL). The combined 
organic layers were dried (MgSO4) and evaporated. Toluene (4 mL) was added to the residue 
and the mixture was made alkaline with 0.880 aqueous ammonia (3 mL). The aqueous layer 
was extracted with toluene (2 x 4 mL), and the organic layers were combined, dried (MgSO4) 
and evaporated. The residue was purified by flash chromatography (20% ethyl 
acetate/hexane) to give 3e (0.27 g, 15%) as a yellow oil; IR νmax 3368 (N-H), 2948 (C-H), 
1726, 1664 cm-1; 1H NMR (500 MHz, CDCl3) (1:1 mixture of diastereoisomers) δ 7.38-7.30 
(5H, m, Ph) 3.69 (3H, s) 3.30 (1H, m) 2.82 (1H, m) 2.60-2.40 (2H, m) 1.65 (2H, br s) 1.26-
1.18 (3H, m); 13C NMR (500 MHz, CDCl3) δ 176.1, 175.9, 139.1, 139.1, 129.4, 129.3, 129.1, 
128.6, 126.5, 55.5, 54.4, 51.7, 51.6, 45.7, 44.6, 41.8, 41.6, 14.5, 11.7; m/z (CI, %) 208 
([M+H]+, 100). HRMS C12H18NO2 calcd. 208.1338, found 208.1335. 
Dihydrochloride salt of methyl 3-amino-3-(pyridin-3-yl)propanoate (3g). 3-Amino-3-
(pyridin-3-yl)propanoic acid was prepared as previously described31 and directly treated with 
thionyl chloride in methanol to give the dihydrochlorde salt of 3g. To a stirred solution of 
pyridine-3-carboxaldehyde (8.24 g, 76.8 mmol) in ethanol (15 mL) were added malonic acid 
(8.0 g, 76.8 mmol) and ammonium acetate (12.0 g, 0.156 mmol). The mixture was heated 
under reflux for 6 h. After allowing to cool, the mixture was filtered and the filtrate 
evaporated. The residue was dissolved in methanol (150 mL) and the solution cooled to 0 °C. 
To the stirred solution thionyl chloride (2.7 mL, 99.8 mmol) was added dropwise; the mixture 
was stirred at 0 °C for an additional 30 min, then stirred at 20 °C for 3 h.  The mixture was 
then heated at reflux for 1 h. After allowing to cool, diethyl ether (200 mL) was added and the 
precipitate filtered to give the dihydrochloride salt of 3g (5.42 g, 43%) as a white solid, mp 
202-205 °C (lit.32 mp 197.5-199 °C); IR νmax 3296, 2953, 1737, 1657 cm-1; 1H NMR (500 
MHz, D2O) δ 8.54 (1H, m) 8.50 (1H, m) 7.90 (1H, m) 7.47 (1H, m) 4.74 (1H, dd, J= 7.9, 6.6 
Hz) 3.70 (3H, s) 2.88 (1H, dd, J= 16.3, 7.9 Hz) 2.80 (1H, dd, J= 16.3, 6.6 Hz). 
Methyl 3-(2-methoxycarbonylacetylamino)butanoate (4a). Following general procedure A, 
reaction of methyl 3-aminobutanoate hydrochloride (0.50 g, 3.3 mmol) in dichloromethane (7 
mL), 1-hydroxybenzotriazole (0.66 g, 4.9 mmol), N,N-diisopropylethylamine (2.3 mL, 13 
mmol), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.59 g, 3.3 mmol), 
and monomethyl malonate (1.52 g, 9.8 mmol) in dichloromethane (10 mL) gave a pale yellow 
solid that was purified by flash chromatography (60% ethyl acetate/hexane) to give 4a (0.33 
g, 46%) as a yellow gum; IR νmax 3293, 2956, 1730, 1650 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.26 (1H, br s) 4.35 (1H, m) 3.63 (3H, s) 3.58 (3H, s) 3.19 (2H, s) 2.51-2.36 (2H, m) 1.13 
(3H, d, J= 6.7 Hz); 13C NMR (500 MHz, CDCl3) δ 171.7, 169.4, 164.3, 52.3, 51.6, 42.2, 41.3, 
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39.8, 19.8; m/z (CI, %) 218 ([M+H]+, 100). HRMS C9H16NO5 calcd. 218.1023, found 
218.1022. 
Methyl 3-(2-methoxycarbonylacetylamino)-hexanoate (4c). Following general procedure 
A, reaction of methyl 3-aminohexanoate 3c (0.47 g, 3.3 mmol) in dichloromethane (7 mL), 1-
hydroxybenzotriazole (0.66 g, 4.9 mmol), N,N-diisopropylethylamine (2.3 mL, 13 mmol), N-
(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.59 g, 3.3 mmol), and 
monomethyl malonate (1.52 g, 9.8 mmol) in dichloromethane (10 mL) gave a pale yellow 
solid that was purified by flash chromatography (55:45 ethyl acetate/hexane) to give 4c (0.32 
g, 40%) as a colourless gum; IR νmax 3292, 2956, 1734, 1649 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.22 (1H, br s) 4.38 (1H, m) 3.74 (3H, s) 3.69 (3H, s) 3.31 (2H, s) 2.56-2.54 (2H, 
m) 1.56-1.49 (2H, m) 1.35 (2H, m) 0.91 (3H, t, J= 7.3 Hz); 13C NMR (300 MHz, CDCl3) δ 
172.1, 169.7, 164.3, 52.4, 51.7, 46.0, 41.2, 38.4, 36.1, 19.3, 13.8; m/z (CI, %) 246 ([M+H]+, 
100). HRMS C11H20NO5 calcd. 246.1336, found 246.1332. 
Methyl 3-(2-methoxycarbonylacetylamino)-2-methylpentanoate (4d). Following general 
procedure B, reaction of ester 3d (0.30 g, 2.07 mmol), triethylamine (0.38 mL, 2.7 mmol), 
and methyl 3-chloro-3-oxopropanoate (0.27 mL, 2.48 mmol) in dichloromethane (8 mL) gave 
a pale yellow oil was purified by flash chromatography (40:60 ethyl acetate/hexane) to give 
4d (0.20 g, 40%) as a pale yellow oil; 1H NMR (300 MHz, CDCl3) (mixture of 
diastereoisomers) δ 7.35 (1H, m) 4.17 (1H, m) 3.75 (3H, s) 3.67 (3H, s) 3.34-3.30 (2H, m) 
2.68 (1H, m) 1.61-1.55 (2H, m) 1.16 (3H, d, J= 6.0 Hz) 0.92 (3H, t, J= 7.2 Hz); 13C NMR 
(300 MHz, CDCl3) δ 175.7, 174.8, 169.6, 169.3, 165.0, 164.8, 52.8, 52.7, 52.4, 52.3, 51.7, 
48.6, 43.3, 42.0, 41.5, 41.2, 26.4, 24.7, 14.7, 12.8, 10.6; m/z (CI, %) 246 ([M+H]+, 100). 
HRMS C11H20NO5 calcd. 246.1342, found 246.1345. 
Methyl 3-(2-methoxycarbonylacetylamino)-2-methyl-4-phenylbutanoate (4e). Following 
general procedure B, reaction of amine 3e (0.13 g, 0.60 mmol), N,N-diisopropylethylamine 
(0.21 mL, 1.21 mmol), and methyl 3-chloro-3-oxopropanoate (0.10 mL, 0.90 mmol) in 
dichloromethane (4 mL) afforded an oil that was purified by flash chromatography (40:60 
ethyl acetate:hexane) to give 4e (0.13 g, 67%) as a colourless oil; IR νmax 3301, 2953, 1733, 
1657 cm-1; 1H NMR (500 MHz, CDCl3) (mixture of diastereoisomers) δ 7.29-7.16 (5H, m) 
4.51-4.13 (1H, m) 3.72 (3H, s) 3.66 (3H, s) 3.27-3.12 (2H, m) 2.84-2.67 (3H, m) 1.22-1.18 
(3H, m); 13C NMR (500 MHz, CDCl3) δ 175.9, 174.8, 169.8, 169.4, 164.8, 164.3, 137.8, 
137.6, 129.3, 129.2, 128.5, 128.4, 126.7, 126.6, 53.1, 52.4, 52.3, 51.9, 42.9, 42.6, 41.5, 41.0, 
40.7, 39.9, 37.8, 37.7, 13.2, 12.9; m/z (EI, %) 308 ([M+H]+, 5), 276 ([M-CH4O]+, 12). HRMS 
C16H22NO5 calcd. 308.1498, found 308.1491. 
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Methyl 3-(2-methoxycarbonylacetylamino)-4-(pyridin-3-yl)butanoate (4g). Following 
general procedure B, reaction of amine 3g (0.50 g, 1.98 mmol), N,N-diisopropylethylamine 
(1.4 mL, 7.93 mmol), and methyl 3-chloro-3-oxopropanoate (0.32 mL, 2.98 mmol) in 
dichloromethane (12 mL) gave an oil was purified by flash chromatography (1:1 ethyl 
acetate:hexane) to give 4g (0.54 g, 97%) as a yellow oil; IR νmax 3273, 2954, 1733, 1656 cm-1; 
1H NMR (500 MHz, CDCl3) (mixture of rotamers) δ 8.67 (1H, s) 8.53 (1H, m) 7.64-7.55 (1H, 
m) 7.22 (1H, m) 5.38 (1H, dd, J= 6.4, 5.3 Hz) 3.67 (3H, s) 3.53 (3H, s) 3.26 (2H, s) 2.86 (1H, 
dd, J= 16.0, 6.4 Hz) 2.79 (1H, dd, J= 16.0, 5.3 Hz); 13C NMR (500 MHz, CDCl3) δ 170.8, 
169.3, 164.8, 148.8, 148.1, 136.2, 134.4, 123.6, 123.3, 52.5, 52.0, 47.9, 41.3, 39.6; m/z (EI, 
%) 281 ([M+H]+, 51), 280 (M+, 88). HRMS C13H17N2O5 calcd. 281.1137, found 281.1136. 
3-Methoxycarbonyl-6-phenylpiperidine-2,4-dione (5f). Sodium methoxide in methanol (2.0 
M, 3.1 mL, 6.2 mmol) was added to a stirred solution of diester 4f25 (1.40 g, 5.0 mmol) in 
methanol (15 mL) at 20 °C under nitrogen. The mixture was then heated under reflux for 2 h. 
After allowing to cool to 20 °C, the mixture was diluted with diethyl ether and filtered. The 
white precipitate was dissolved in water, and the solution acidified to pH 2-3 by hydrochloric 
acid (1M). After extraction with ethyl acetate (3 x 20 mL) the combined organic layers were 
washed with brine (10 mL), dried (MgSO4) and evaporated to give 5f (0.86 g, 70%) as a white 
solid, mp 122-125 °C (lit.13 128-130 °C); IR νmax 3311 (O-H), 2952, 1713, 1638, 1571 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.27-7.14 (5H, m) 6.22 (1H, br s) 4.64 (1H, t, J= 7.5 Hz) 3.68 
(3H, s) 2.81 (2H, d, J= 7.5 Hz); 13C NMR (500 MHz, CDCl3) δ 183.5, 172.0, 164.8, 139.6, 
129.1, 128.7, 126.5, 97.4, 52.7, 52.3, 37.8. 
6-Methylpiperidine-2,4-dione (6a). Following general procedure C, reaction of diester 4a 
(0.30 g, 1.38 mmol), and sodium methoxide in methanol (1.84 M, 1.5 mL, 2.76 mmol) in 
methanol (2.0 mL) gave 6a (74 mg, 42%) as a pale yellow solid, mp 124-128 °C; IR νmax 
3217, 2968, 1726, 1663, cm-1; 1H NMR (500 MHz, CDCl3) δ 3.88 (1H, m) 3.26 (2H, d, J= 
19.8 Hz) 3.19 (1H, d, J= 19.8 Hz) 2.64 (1H, dd, J= 16.4, 4.0 Hz) 2.30 (1H, dd, J= 16.4, 9.6 
Hz) 1.30 (3H, d, J= 6.5 Hz); 13C NMR (500 MHz, CDCl3) δ 203.4, 169.8, 47.0, 46.2, 44.6, 
21.3; m/z (CI, %) 128 ([M+H]+, 100). HRMS C6H10NO2 calcd. 128.0711, found 128.0714. 
6-Propylpiperidine-2,4-dione (6c). Following general procedure C, reaction of diester 4c 
(0.17 g, 0.70 mmol), and sodium methoxide in methanol (2.0 M, 0.54 mL, 1.05 mmol) in 
methanol (1.0 mL) gave 6c (63 mg, 58%) as a white solid, mp 112-116 °C; IR νmax 3249, 
2925, 1736, 1664 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.65 (1H, m) 3.25 (2H, m) 2.66 (1H, 
m) 2.33 (1H, m) 1.50-1.22 (4H, m) 0.93 (3H, m); 13C NMR (500 MHz, CDCl3) δ 208.0, 176.1, 
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36.9, 34.0, 29.7, 21.1, 18.4, 13.9; m/z (CI, %) 156 ([M+H]+, 35). HRMS C8H14NO2 calcd. 
156.1025, found 156.1022. 
6-Ethyl-5-methylpiperidine-2,4-dione (6d). Following general procedure C, reaction of 
diester 5d (0.12 g, 0.48 mmol), and sodium methoxide in methanol (1.74 M, 0.53 mL, 0.92 
mmol) in methanol (3.0 mL) gave 6d (53 mg, 71%) as a yellow oil; IR νmax 3280, 2925, 1725, 
1661 cm-1; 1H NMR (300 MHz, CDCl3) (mixture of diastereoisomers) δ 7.95-7.79 (1H, br s) 
3.75-3.69 (1H, m) 3.22 (2H, m) 2.67-2.36 (1H, m) 1.73-1.52 (2H, m) 1.19-1.05 (3H, m) 0.99-
0.83 (3H, m); 13C NMR (300 MHz, CDCl3) δ 205.7, 170.0, 55.6, 54.5, 46.4, 46.4, 46.0, 41.0, 
26.2, 24.4, 11.6, 10.1, 10.0, 8.5; m/z (CI, %) 156 ([M+H]+, 100). HRMS C8H14NO2 calcd. 
156.2023, found 156.2021. 
6-Benzyl-5-methylpiperidine-2,4-dione (6e). Following general procedure C, reaction of 
diester 5e (0.09 g, 0.30 mmol), and sodium methoxide in methanol (2.0 M, 0.2 mL, 0.38 
mmol) in methanol (1.2 mL) gave 6e (36 mg, 56%) as a yellow oil, IR νmax 3245 (N-H), 2923, 
1721, 1661 cm-1; 1H NMR (500 MHz, CDCl3) (mixture of diastereoisomers) δ 7.63-7.19 (5H, 
m) 3.92-3.83 (1H, m) 3.27-3.13 (2H, m) 2.90 (1H, m) 2.65-2.61 (1H, m) 2.51-2.46 (1H, m) 
1.28-1.25 (3H, m); 13C NMR (500 MHz, CDCl3) δ 204.8, 204.7, 169.2, 168.4, 136.0, 135.5, 
129.5, 129.4, 129.3, 129.1, 127.7, 127.4, 55.8, 54.5, 47.4, 46.6, 46.1, 46.0, 41.0, 37.9, 12.1, 
10.5; m/z (CI, %) 218 (M+H+, 100). HRMS C13H16NO2 calcd. 218.1181, found 218.1189. 
6-Phenylpiperidine-2,4-dione (6f). Diester 5f (0.31 g, 1.25 mmol) was added to 1% water in 
acetonitrile (6 mL). The mixture was heated under reflux for 2 h, allowed to cool and then 
evaporated. The residue was purified by flash chromatography (1:99 methanol:chloroform) to 
give 6f (0.25 g, 95%) as a white solid, mp 160-163 °C (lit.33 167-169 °C); IR νmax 3248, 2927, 
1722, 1664 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.47-7.28 (5H, m) 6.87 (1H, br s) 4.80 (1H, 
dd, J= 8.7, 4.5 Hz) 3.34 (2H, s) 2.88 (1H, dd, J= 16.0, 4.5 Hz) 2.88 (1H, dd, J= 16.0, 8.7 Hz); 
13C NMR (500 MHz, CDCl3) δ 202.3, 169.0, 139.3, 129.4, 128.9, 126.0, 52.9, 47.2, 47.0; m/z 
(CI, %) 190 ([M+H]+, 95). HRMS C11H12NO2 calcd. 190.0863, found 190.0859.  
3,3-Dimethyl-6-phenylpiperidine-2,4-dione (6h). Potassium carbonate (0.25 g, 1.84 mmol) 
and methyl iodide (0.11 mL, 1.84 mmol) were added to a solution of 6-phenylpiperidine-2,4-
dione (6f) (0.12 g, 0.61 mmol) in acetone (3 mL). The mixture was stirred at 50 °C for 16 h. 
Filtration and evaporation of the filtrate gave a residue that was purified by flash 
chromatography (60:40 ethyl acetate/hexane) to give 6h (0.09 g, 65%) as a white solid, mp 
165-168 °C (lit.34 168-169 °C); IR νmax 3200, 2978, 1714, 1649 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.60-7.26 (5H, m) 6.60 (1H, br s) 4.70 (1H, dd, J= 4.7, 2.5 Hz) 2.92 (1H, dd, J= 
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15.5, 4.7 Hz) 2.84 (1H, dd, J= 15.5, 2.5 Hz) 1.39 (3H, s) 1.38 (3H, s); 13C NMR (300 MHz, 
CDCl3) δ 208.2, 175.8, 140.0, 129.3, 128.8, 126.0, 52.1, 52.0, 45.3, 23.1, 22.8. 
3-Methoxycarbonyl-3-methyl-6-phenylpiperidine-2,4-dione (6i). Tetrabutylammonium 
fluoride in THF (1M, 0.8 mL) and methyl iodide (0.08 mL, 1.28 mmol) were added to 3-
methoxycarbonyl-6-phenylpiperidine-2,4-dione (5f) (0.16 g, 0.64 mmol) in THF (2 mL). The 
mixture was stirred at 20 °C for 24 h. The solution was neutralised with hydrochloric acid 
(1M), extracted with chloroform and evaporated. The residue that was purified by flash 
chromatography (55:45 ethyl acetate:hexane) to give 6i (0.11 g, 64%) as a colourless solid; 1H 
NMR (300 MHz, CDCl3) (1:1 mixture of diastereoisomers) δ 7.47-7.21 (5H, m) 6.60 (1H, br 
s) 4.82-4.49 (1H, m) 3.69 and 3.64 (3H, s) 3.04-2.73 (2H, m) 1.57 and 1.51 (3H, s); 13C NMR 
(300 MHz, CDCl3) δ 201.7, 201.6, 170.3, 169.6, 167.6, 167.5, 139.3, 139.2, 129.4, 129.3, 
129.0, 128.9, 126.2, 126.1, 63.8, 63.7, 53.5, 53.4, 52.4, 52.0, 45.7,  45.6, 18.3, 18.2; m/z (CI, 
%) 262 ([M+H]+, 100). HRMS C14H16NO4 calcd. 262.1074, found 262.1067. 
Methyl (3S,αS)-3-[N-allyl-N-(α-methylbenzyl)]aminobutanoate (8a). Following general 
procedure D, butyllithium in hexanes (1.6 M, 8.0 mL, 12.9 mmol) and methyl but-2-enoate 
(0.83 g, 8.3 mmol) in anhydrous THF (9 mL) were added to (S)-N-(α-
methylbenzyl)allylamine (7) (2.15 g, 13.3 mmol) in anhydrous THF (18 mL), affording an oil 
that was purified by flash chromatography (15:85 ethyl acetate:hexane) to give 8a (1.85 g, 
85%) as a pale yellow oil; [α]D21 = +18.7 (c 0.75, CHCl3), lit.35 for enantiomer [α]D26 = -14.2 
(c 1.85, CHCl3); IR νmax 2970, 1737 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.37-7.20 (5H, m) 
5.85 (1H, m) 5.15 (1H, dd, J= 17.2, 10.4 Hz) 5.04 (1H, dd, J= 17.2, 4.6 Hz) 3.97 (1H, q, J= 
6.8 Hz) 3.56 (3H, s) 3.49 (1H, m) 3.18 (2H, d, J= 6.3 Hz) 2.40 (1H, dd, J=14.2, 7.0 Hz) 2.19 
(1H, dd, J=14.2, 7.5 Hz) 1.37 (3H, d, J= 6.8 Hz) 1.07 (3H, d, J= 6.8 Hz); 13C NMR (500 
MHz, CDCl3) δ 172.9, 145.2, 139.2, 128.1, 127.6, 126.8, 115.6, 57.7, 51.4, 50.6, 48.6, 40.4, 
18.8, 17.5; m/z (CI, %) 262 ([M+H]+). HRMS C16H24NO2 calcd. 262.1807, found 262.1803. 
Methyl (3R,αS)-3-[N-allyl-N-(α-methylbenzyl)amino]-4-methylpentanoate (8b). 
Following general procedure D, butyllithium in hexanes (2.5 M, 5.3 mL, 13.3 mmol) and 
methyl 4-methylpent-2-enoate (1.10 g, 8.58 mmol) in anhydrous THF (22 mL) were added to 
(S)-N-(α-methylbenzyl)allylamine (7) (2.22 g, 13.7 mmol) in anhydrous THF (28 mL), 
affording an oil that was purified by flash chromatography (12:88 ethyl acetate:hexane) to 
give 8b (1.70 g, 69%) as a pale yellow oil; [α]D21 = +18.0 (c 5.00, CHCl3); IR νmax 2970, 1736 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.31-7.21 (5H, m) 5.90 (1H, m) 5.20 (1H, m) 5.07 (1H, 
m) 3.91 (1H, q, J= 7.1 Hz) 3.58 (3H, s) 3.18 (1H, m) 3.09-3.06 (2H, m) 2.11 (1H, dd, J= 15.6, 
7.8 Hz) 2.02 (1H, dd, J= 15.6, 4.0 Hz) 1.69 (1H, m) 1.43 (3H, d, J= 7.1 Hz) 0.98 (3H, d, J= 
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6.7 Hz) 0.81 (3H, d, J= 6.7 Hz); 13C NMR (500 MHz, CDCl3) δ 174.0, 143.9, 139.2, 128.3, 
127.9, 126.8, 115.4, 59.8, 58.9, 51.4, 49.7, 35.0, 32.8, 21.0, 20.9, 19.8; m/z (CI, %) 290 
([M+H]+, 40) 246 ([M-C3H6]+, 100) 105 (C8H9+, 30). HRMS C18H28NO2 calcd. 290.2120, 
found 290.2123. 
Methyl (3R,αS)-3-[N-allyl-N-(α-methylbenzyl)amino]hex-4-enoate (8c). Following general 
procedure D, butyllithium in hexanes (1.6 M, 11.3 mL, 18.0 mmol) and (E,E)-methyl hexa-
2,4-dienoate (1.47 g, 11.6 mmol) in anhydrous THF (15 mL) were added to (S)-N-(α-
methylbenzyl)allylamine (7) (3.00 g, 18.6 mmol) in anhydrous THF (15 mL), affording an oil 
that was purified by flash chromatography (1:9 ethyl acetate:hexane) to give 8c (2.61 g, 78%) 
as a pale yellow oil; [α]D21 = +3.4 (c 2.95, CHCl3), lit.17a for enantiomer [α]D13 = -2.4 (c 1.00, 
CHCl3); IR νmax 2970, 1736 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.35-7.17 (5H, m) 5.80 (1H, 
m) 5.51 (2H, m) 5.12-5.00 (2H, m) 4.02 (1H, q, J= 6.8 Hz) 3.85 (1H, m) 3.56 (3H, s) 3.12 
(2H, m) 2.51 (1H, dd, J= 14.3, 5.8 Hz) 2.34 (1H, dd, J= 14.3, 7.5 Hz) 1.69 (3H, d, J= 4.6 Hz) 
1.35 (3H, d, J= 6.8 Hz); 13C NMR (500 MHz, CDCl3) δ 172.5, 145.2, 138.8, 130.6, 128.0, 
127.6, 127.1, 126.5, 115.7, 56.9, 56.8, 51.4, 49.6, 38.9, 18.1, 18.0; (EI, %) 288 ([M+H]+, 20), 
105 (C8H9+, 100). HRMS C18H26NO2 calcd. 288.1964, found 288.1961. 
Methyl (3R,αS)-3-[N-allyl-N-(α-methylbenzyl)]-3-phenylpropanoate (8f). Following 
general procedure D, butyllithium in hexanes (2.5 M, 3.8 mL, 9.56 mmol) and methyl (E)-
cinnamate (1.00 g, 6.17 mmol) in anhydrous THF (16 mL) to (S)-N-(α-
methylbenzyl)allylamine (7) (1.59 g, 9.86 mmol) in anhydrous THF (20 mL), affording an oil 
that was purified by flash chromatography (10:9 ethyl acetate:hexane) to give 8f (1.80 g, 
90%) as a pale yellow oil; [α]D21 = +1.5 (c 4.10, CHCl3), lit.35 for enantiomer [α]D26 = -3.6 (c 
0.85, CHCl3); IR νmax 2973, 1736 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.55-7.33 (10H, m) 
5.80 (1H, m) 5.17 (1H, ddd, J= 17.2, 8.6, 1.4 Hz) 5.08 (1H, ddd, J= 17.2, 10.1, 1.4 Hz) 4.54 
(1H, m) 4.08 (1H, q, J= 6.7 Hz) 3.57 (3H, s) 3.22-3.18 (2H, m) 2.91 (1H, dd, J= 14.6, 5.6 Hz) 
2.69 (1H, dd, J= 14.6, 8.3 Hz) 1.18 (3H, d, J= 6.7 Hz); 13C NMR (500 MHz, CDCl3) δ 172.5, 
144.9, 141.5, 138.8, 128.4, 128.1, 127.7, 127.5, 127.3, 126.7, 116.0, 58.9, 56.3, 51.5, 49.8, 
38.0, 16.6; m/z (CI, %) 324 ([M+H]+, 18), 105 (C8H9+, 100). HRMS C21H26NO2 calcd. 
324.1964, found 324.1958). 
Methyl (3R,αS)-3-[N-allyl-N-(α-methylbenzyl)]-3-(3-pyridyl)propanoate (8g). Following 
general procedure D, butyllithium in hexanes (2.5 M, 1.9 mL, 4.75 mmol) and methyl 3-
(pyridin-3-yl)propenoate (0.50 g, 3.06 mmol) in anhydrous THF (5 mL) (S)-N-(α-
methylbenzyl)allylamine (7) (0.95 g, 4.09 mmol) in anhydrous THF (10 mL) afforded an oil 
that was purified by flash chromatography (1:1 ethyl acetate:hexane) to give 8g (0.52 g, 48%) 
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as a yellow oil; [α]D21 = -0.6 (c 1.70, CHCl3); IR νmax 2972, 1735 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 8.61 (1H, s) 8.50 (1H, m) 7.67 (1H, d, J= 7.9 Hz) 7.37-7.22 (6H, m) 5.78 (1H, m) 
5.16 (2H, ddd, J= 17.2, 4.8, 1.5 Hz) 5.07 (2H, ddd, J= 17.2, 10.2, 1.5 Hz) 4.54 (1H, m) 4.02 
(1H, q, J= 6.8 Hz) 3.55 (3H, s) 3.19-3.13 (2H, m) 2.81 (1H, dd, J=15.2, 6.0 Hz) 2.67 (1H, dd, 
J=15.2, 9.0 Hz) 1.23 (3H, d, J= 6.8 Hz); 13C NMR (500 MHz, CDCl3) δ 172.0, 149.7, 148.6, 
144.2, 138.2, 137.2, 135.3, 128.3, 127.5, 127.0, 123.3, 116.4, 56.9, 56.6, 51.7, 49.8, 36.7, 
17.6; m/z (EI, %) 325 ([M+H]+, 15), 105 (C8H9+, 100). HRMS C20H25N2O2 calcd. 325.1916, 
found 325.1916. 
Methyl (3R,αS)-3-[N-allyl-N-(α-methylbenzyl)amino]-3-cyclohexylpropanoate (8k). 
Following general procedure D, butyllithium in hexanes (2.5 M, 6.6 mL, 16.6 mmol) and 
methyl 3-cyclohexylpropenoate (1.80 g, 10.7 mmol) in anhydrous THF (27 mL) were added 
to (S)-N-(α-methylbenzyl)allylamine (7) (2.76 g, 17.1 mmol) in anhydrous THF (34 mL), 
affording an oil that was purified by flash chromatography (12:88 ethyl acetate:hexane) to 
give 8k (2.40 g, 68%) as a pale yellow oil; [α]D25 = +11.0 (c 6.69, CHCl3); IR νmax 2923, 1735 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.30-7.19 (5H, m) 5.85 (1H, m) 5.20 (1H, m) 5.07 (1H, 
m) 3.90 (1H, q, J= 7.0 Hz) 3.57 (3H, s) 3.17-3.12 (2H, m) 3.06 (1H, m) 2.17-2.08 (2H, m) 
2.00 (1H, dd, J= 15.7, 3.7 Hz) 1.57-1.42 (4H, m) 1.39 (3H, d, J= 7.0 Hz) 1.17-1.12 (4H, m) 
0.88-0.76 (2H, m); 13C NMR (500 MHz, CDCl3) δ 174.0, 143.9, 139.2, 128.3, 127.9, 126.8, 
115.4, 58.8, 51.4, 49.8, 42.7, 34.7, 31.1, 30.2, 27.0, 26.6, 21.0; m/z (CI, %) 330 ([M+H]+, 20) 
246 ([M-C7H10]+, 100). HRMS C21H32NO2 calcd. 330.2433, found 330.2439. 
Methyl (3S,αS)-3-[N-(α-methylbenzyl)]-butanoate (9a). Following general procedure E, 
reaction of amine 8a (1.00 g, 3.83 mmol) and Wilkinson’s catalyst (180 mg, 0.19 mmol) in 
acetonitrile-water (85:15, 20 mL) at 20 °C afforded an oil that was purified by flash 
chromatography (15:85 ethyl acetate:hexane) to give 9a (0.73 g, 87%) as a pale brown oil; 
[α]D21 = -22.5 (c 1.29, CHCl3); IR νmax (cm-1) 2960, 2923, 1731 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.69-7.22 (5H, m,) 3.87 (1H, q, J= 6.7 Hz) 3.66 (3H, s) 3.00 (1H, m) 2.46 (1H, m) 
2.37 (1H, m) 1.68 (1H, br s) 1.33 (3H, d, J= 6.7 Hz) 1.05 (3H, d, J= 6.7 Hz); 13C NMR (500 
MHz, CDCl3) δ 172.8, 132.0, 128.6, 127.0, 126.6, 55.3, 51.5, 47.8, 40.6, 24.6, 21.5; m/z (CI, 
%) 222 ([M+H]+, 100). HRMS C13H20NO2 calcd. 222.1494, found 292.1491. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl)]-4-methylpentanoate (9b). Following general 
procedure E, reaction of amine 8b (1.50 g, 5.18 mmol) and Wilkinson’s catalyst (0.24 g, 0.26 
mmol) in acetonitrile-water (85:15, 30 mL) at 20 °C afforded an oil that was purified by flash 
chromatography (18:82 ethyl acetate:hexane) to give 9b (0.77 g, 59%) as a pale yellow oil; 
[α]D21 = -48.1 (c 2.35, CHCl3); IR νmax 2957, 1733 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38-
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7.20 (5H, m) 3.84 (1H, m) 3.67 (3H, s) 2.65 (1H, q, J= 6.3 Hz) 2.45 (1H, dd, J= 14.6, 9.0 Hz) 
2.37 (1H, dd, J= 14.6, 5.5 Hz) 1.67 (1H, m) 1.31 (3H, d, J= 6.3 Hz) 0.87 (3H, d, J= 6.8 Hz) 
0.80 (3H, d, J= 6.8 Hz); 13C NMR (500 MHz, CDCl3) δ 173.5, 132.0, 128.3, 126.9, 126.5, 
57.6, 55.5, 51.5, 35.9, 31.4, 24.9, 18.6, 18.5; m/z (CI, %) 250 ([M+H]+, 100) 206 ([M-C3H6]+, 
53). HRMS C15H24NO2 calcd. 250.1807, found 250.1805. 
(4E)-Methyl (3R,αS)-3-[N-(α-methylbenzyl)]hex-4-enoate (9c). Following general 
procedure E, reaction of amine 8c (5.10 g, 17.8 mmol) and Wilkinson’s catalyst (0.82 g, 0.89 
mmol) in acetonitrile-water (85:15, 120 mL) at 20 °C afforded an oil that was purified by 
flash chromatography (1:9 ethyl acetate:hexane) to give 9c (3.69 g, 84%) as a pale yellow oil; 
[α]D21 = -38.9 (c 0.72, CHCl3); IR νmax 3060, 2965, 1734 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.57-7.04 (5H, m) 5.55 (1H, m) 5.27 (1H, m) 3.83 (1H, q, J= 6.5 Hz) 3.66 (3H, s) 3.48 (1H, 
m) 2.52-2.46 (2H, m) 1.63 (3H, dd, J= 6.5, 1.4 Hz) 1.31 (3H, d, J= 6.5 Hz); 13C NMR (500 
MHz, CDCl3) δ 172.5, 146.2, 132.7, 128.5, 127.1, 126.9, 126.7, 54.9, 54.7, 51.5, 40.5, 23.3, 
17.8; (EI, %) 247 ([M+H]+, 5) 232 ([M-CH3]+, 38), 105 (C8H9+, 100). HRMS C15H22NO2 
calcd. 248.1650, found 248.1651. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl)]-3-phenylpropanoate (9f). Following general 
procedure E, reaction of amine 8f (0.50 g, 1.55 mmol) and Wilkinson’s catalyst (72 mg, 0.08 
mmol) in acetonitrile-water (85:15, 10 mL) at 20 °C gave an oil that was purified by flash 
chromatography (1:4 ethyl acetate:hexane) to give 9f (0.33 g, 76%) as a pale yellow oil; 
[α]D21 = -13.5 (c 7.47, CHCl3), lit.36 [α]D20 = -16.3 (c 1.00, CHCl3); IR νmax 3050, 2964, 1732 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.33-7.21 (10H, m) 4.21 (1H, m) 3.66 (1H, q, J= 6.6 Hz) 
3.62 (3H, s) 2.77 (1H, m) 2.68 (1H, m) 1.85 (1H, br s) 1.23 (3H, d, J= 6.6 Hz); 13C NMR (500 
MHz, CDCl3) δ 172.2, 132.0, 128.6, 128.5, 127.5, 127.1, 126.7, 56.9, 54.8, 51.6, 42.5, 22.2; 
m/z (CI, %) 284 ([M+H]+, 100).  HRMS C18H22NO2 calcd. 284.1651, found 284.1648. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl)]-3-(pyridin-3-yl)propanoate (9g). 
Tetrakis(triphenylphosphine)palladium(0) (0.16 g, 0.01 mmol) and dimethylbarbituric acid 
(0.73 g, 2.98 mmol) were added to a stirred solution of amine 8g (0.54 g, 1.51 mmol) in 
anhydrous dichloromethane (80 mL) at 30 °C under nitrogen. After stirring the solution at 30 
°C for a further 3 h the mixture was washed with aqueous saturated sodium carbonate (2 x 10 
mL), and the combined organic layers dried (MgSO4) and evaporated to give an oil that was 
purified by flash chromatography (6:4 ethyl acetate:hexane) to give 9g (0.41 g, 96%) as an 
orange oil; IR νmax 2982, 2920, 1732 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.47 (1H, s) 8.40 
(1H, m) 7.65 (1H, m) 7.43-7.14 (6H, m) 4.17 (1H, dd, J=7.5, 6.3 Hz) 3.65 (1H, q, J= 6.4 Hz) 
3.58 (3H, s) 2.75 (1H, dd, J=15.5, 7.5 Hz) 2.63 (1H, dd, J=15.5, 6.3 Hz) 2.25 (1H, br s, NH) 
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1.33 (3H, d, J= 6.4 Hz); 13C NMR (500 MHz, CDCl3) δ 171.7, 149.3, 148.8, 145.4, 138.2, 
133.7, 132.0, 128.9, 128.5, 127.1, 55.4, 54.9, 51.7, 41.8, 22.9; m/z (CI, %) 285 ([M+H]+, 
100). HRMS C17H21N2O2 calcd. 285.1603, found 285.1607. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl)]-3-cyclohexylpropanoate (9k). Following general 
procedure E, reaction of amine 8k (1.86 g, 5.65 mmol) and Wilkinson’s catalyst (0.30 g, 0.32 
mmol) in 85:15 acetonitrile:water (35 mL) at 20 °C afforded an oil that was purified by flash 
chromatography (12:88 ethyl acetate:hexane) to give 9k (0.79 g, 53%) as a yellow oil; [α]D25 
= -35.2 (c 1.90, CHCl3); IR νmax 2985, 2922, 1732 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35-
7.20 (5H, m) 3.80 (1H, m) 3.67 (3H, s) 2.63 (1H, q, J= 5.9 Hz) 2.49 (1H, dd, J= 14.7, 5.5 Hz) 
2.37 (1H, dd, J= 14.7, 6.3 Hz) 1.79-1.62 (5H, m) 1.31 (3H, d, J= 5.9 Hz) 1.17-1.08 (4H, m) 
0.96-0.86 (2H, m); 13C NMR (500 MHz, CDCl3) δ 173.5, 132.0, 128.3, 127.0, 126.9, 57.0, 
55.5, 51.5, 41.8, 35.9, 29.3, 29.1, 26.6, 26.5; m/z (CI, %) 290 ([M+H]+, 100). HRMS 
C18H28NO2 calcd. 290.2120, found 290.2112. 
Methyl (3S,αS)-3-[N-(α-methylbenzyl), N-(2-methoxycarbonylacetyl)]butanoate (10a). 
Following general procedure B, reaction of amine 9a (0.30 g, 1.36 mmol), triethylamine (0.22 
mL, 1.63 mmol) and methyl 3-chloro-3-oxopropanoate (0.16 mL, 1.5 mmol) in 
dichloromethane (6 mL) afforded an oil that was purified by flash chromatography (1:1 ethyl 
acetate:hexane) to give 10a (0.25 g, 58%) as a colourless oil; [α]D21 = -2.5 (c 0.80, CHCl3); IR 
νmax 2952, 1736, 1646 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38-7.22 (5H, m) 4.95 (1H, q, J= 
6.8 Hz) 3.78 (3H, s) 3.60 (3H, s) 3.46 (2H, s) 3.08 (1H, m) 2.42 (1H, m) 2.08 (1H, m) 1.66 
(3H, d, J= 6.8 Hz) 1.43 (3H, d, J= 6.7 Hz); 13C NMR (500 MHz, CDCl3) δ 172.3, 168.3, 
165.6, 139.0, 128.3, 128.1, 127.3, 56.9, 52.6, 51.4, 48.6, 42.9, 39.1, 18.7, 17.3; m/z (CI, %) 
321 (M+, 5) 220 ([M-C4H5O3]+, 85) 105 (C8H9+, 100). HRMS C17H23NO5 calcd. 321.1576, 
found 321.1571. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl)], N-(2-methoxycarbonylacetyl)]-4-
methylpentanoate (10b). Following general procedure B, reaction of amine 9b (0.25 g, 1.0 
mmol), triethylamine (0.18 mL, 1.30 mmol) and methyl 3-chloro-3-oxopropanoate (0.13 mL, 
1.2 mmol) in dichloromethane (4 mL) afforded a pale yellow oil that was purified by flash 
chromatography (1:1 ethyl acetate:hexane) to give 10b (0.18 g, 50%) as a pale yellow oil; 
[α]D21 = +74.3 (c 0.35, CHCl3); IR νmax 2953, 1738, 1647 cm-1; 1H NMR (500 MHz, CDCl3) 
(presence of rotamers) δ 7.35-7.22 (5H, m) 5.00 (1H, m) 3.95 (1H, d, J= 15.7 Hz, rotamer A) 
3.78 (3H, s) 3.72 (1H, d, J= 15.2 Hz, rotamer B) 3.68 (1H, d, J= 15.7 Hz, rotamer A) 3.60 
(1H, d, J= 15.2 Hz, rotamer B) 3.46 and 3.36 (3H, s) 3.27 (1H, m) 2.72 (1H, dd, J= 18.0, 6.9 
Hz) 2.24 (1H, dd, J= 18.0, 2.5 Hz) 2.04 (1H, m) 1.88 and 1.65 (3H, d, J= 7.0 Hz) 1.11 and 
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0.99 (3H, d, J= 6.7 Hz) 0.92 and 0.81 (3H, d, J= 6.8 Hz); 13C NMR (500 MHz, CDCl3) δ 
172.7, 171.9, 168.6, 168.4, 167.6,  165.9, 139.2, 128.8, 128.3, 127.9, 127.7, 126.8, 126.6, 
62.3, 58.3, 56.6, 55.6, 52.6, 52.4, 51.9, 51.4, 43.0, 42.8, 39.6, 35.9, 31.2, 30.9, 21.4, 21.2, 
20.7, 20.1, 19.9, 18.3; m/z (CI, %) 372 ([M+Na+],100). HRMS C19H27NO5Na calcd. 372.1787, 
found 372.1783. 
(4E)-Methyl (3R,αS)-3-[N-(α-methylbenzyl)], N-(2-methoxycarbonylacetyl)]hex-4-enoate 
(10c). Following general procedure B, reaction of amine 9c (1.2 g, 4.85 mmol), triethylamine 
(0.80 mL, 5.8 mmol) and methyl 3-chloro-3-oxopropanoate (0.57 mL, 5.3 mmol) in 
dichloromethane (25 mL) afforded an oil that was purified by flash chromatography (3:7 ethyl 
acetate:hexane) to give 10c (1.58 g, 94%) as a colourless oil; [α]D21 = +5.5 (c 1.82, CHCl3); 
IR νmax 3030 (N-H), 2952, 1733, 1641 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.38-7.21 (5H, m) 
5.93 (1H, m) 5.65-5.56 (2H, m) 5.04 (1H, q, J= 6.7 Hz) 3.78 (3H, s) 3.51 (2H, s) 3.45 (3H, s) 
1.74 (2H, d, J= 4.9 Hz) 1.64 (3H, d, J= 6.7 Hz) 1.58 (3H, m); m/z (CI, %) 370 (M+, 100), 311 
([M-CO2Me]+, 2). HRMS C19H25NO5Na calcd. 370.1630, found 370.1626. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl), N-(2-methoxycarbonylacetyl)]-3-
phenylpropanoate (10f). Following general procedure B, reaction of amine 9f (4.16 g, 14.7 
mmol), triethylamine (2.7 mL, 19 mmol) and methyl 3-chloro-3-oxopropanoate (1.9 mL, 17.6 
mmol) in dichloromethane (45 mL) afforded an oil that was purified by flash chromatography 
(35:65 ethyl acetate:hexane) to give 10f (4.48 g, 80%) as a colourless oil; [α]D21 = +25.0 (c 
1.56, CHCl3); IR νmax 2950, 1735, 1647 cm-1; 1H NMR (300 MHz, CDCl3) (presence of 
rotamers) δ 7.37-7.17 (10H, m) 5.32 and 5.24 (1H, m) 4.98 (1H, q, J= 6.1 Hz) 3.71 (3H, s) 
3.56 (2H, s) 3.51 (3H, s) 3.36-3.31 (2H, m) 2.96 (1H, m) 2.73-2.65 (1H, m) 1.25 (3H, J= 6.1 
Hz); 13C NMR (500 MHz, CDCl3) δ 171.9, 171.1, 168.4, 168.2, 167.2, 166.5, 141.4, 140.4, 
139.9, 139.0, 129.1, 129.0, 128.6, 128.5, 128.2, 128.0, 127.4, 127.2, 127.0, 126.6, 126.5, 56.8, 
56.4, 55.2, 54.7, 52.6, 52.5, 52.1, 51.8, 43.0, 40.8, 38.9, 38.3 18.6; m/z (CI, %) 384 ([M-H]+, 
100). HRMS C22H26NO5Na calcd. 384.1811, found 384.1803. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl), N-(2-methoxycarbonylacetyl)]-3-(pyridin-3-
yl)propanoate (10g). Following general procedure B, reaction of amine 9f (0.16 g, 0.56 
mmol), triethylamine (0.11 mL, 0.73 mmol) and methyl 3-chloro-3-oxopropanoate (0.07 mL, 
0.67 mmol) in dichloromethane (3 mL) afforded an oil that was purified by flash 
chromatography (1:1 ethyl acetate:hexane) to give 10g (0.16 g, 75%) as a colourless oil; 
[α]D21 = +15.0 (c 1.00, CHCl3); IR νmax 2952, 1735, 1648 1496 cm-1; 1H NMR (500 MHz, 
CDCl3) (presence of rotamers) δ 8.57 (1H, s) 8.40 (1H, m) 7.82 (1H, d, J= 7.3 Hz) 7.64 (1H, 
m) 7.45-7.17 (5H, m) 5.08 (1H, q, J= 6.5 Hz) 4.86 (1H, dd, J= 7.7, 5.6 Hz) 3.74 (3H, s) 3.58 
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(2H, s) 3.43 (3H, s) 2.60 (1H, dd, J= 17.1, 7.7 Hz) 2.27 (1H, dd, J= 17.1, 5.6 Hz) 1.60 (3H, d, 
J= 6.5 Hz); 13C NMR (500 MHz, CDCl3) δ 171.6, 168.1, 166.2, 149.0, 148.5, 136.1, 135.7, 
132.1, 132.0, 129.1, 128.8, 128.4, 127.2, 123.3, 57.3, 53.3, 52.6, 51.8, 42.7, 38.7, 18.4; m/z 
(CI, %) 385 ([M+H]+, 100) 279 ([M-C8H8]+, 55). HRMS C21H25N2O5 calcd. 385.1764, found 
385.1761. 
Methyl (3R,αS)-3-[N-(α-methylbenzyl), N-(2-methoxycarbonylacetyl)]-3-
cyclohexylpropanoate (10k). Following general procedure B, reaction of amine 9k (0.25 g, 
0.86 mmol), triethylamine (0.16 mL, 1.12 mmol) and methyl 3-chloro-3-oxopropanoate (0.11 
mL, 1.04 mmol) in dichloromethane (4 mL) afforded a pale yellow oil that was purified by 
flash chromatography (1:1 ethyl acetate:hexane) to give 10k (0.22 g, 66%) as a pale yellow 
oil, [α]D25 = +22.5 (c 1.00, CHCl3); IR νmax 2925, 1737, 1648 cm-1; 1H NMR (500 MHz, 
CDCl3) (presence of rotamers) δ 7.32-7.16 (5H, m) 4.99-4.95 and 4.30-4.28 (1H, m) 3.77 
(3H, s) 3.65 (1H, s) 3.60 (1H, s) 3.40 (3H, s) 2.72 and 2.46 (1H, d, J= 7.0 Hz) 2.45-2.02 (2H, 
m) 1.84 (3H, d, J= 7.0 Hz) 1.73-1.61 (5H, m) 1.29-0.82 (6H, m); 13C NMR (500 MHz, CDCl3) 
δ 173.5, 172.7, 168.7, 168.4, 167.6, 165.8, 142.6, 139.3, 128.7, 128.3, 128.2, 127.9, 126.9, 
126.8, 61.4, 57.2 , 57.0, 55.5, 52.5, 51.5, 51.3, 50.0, 43.0, 42.8 41.8, 40.8, 35.9, 31.5, 30.6, 
30.1, 29.2, 29.1, 26.6, 26.5, 26.4, 26.3, 26.1, 26.0, 25.0, 21.2; m/z (CI, %) 412 ([M+Na]+, 
100). HRMS C22H31NO5Na calcd. 412.2100, found 412.2115. 
 (1S,6R)-1-(α-Methylbenzyl)-3-methoxycarbonyl-6-phenylpiperidine-2,4-dione sodium 
salt (11f). Sodium methoxide in methanol (1.97 M, 0.2 mL, 0.38 mmol) was added to a 
stirred solution of diester 10f (0.13 g, 0.34 mmol) in methanol (0.70 mL) at 20 °C, under 
nitrogen. The mixture was then heated under reflux for 1 h, allowed to cool to 20 °C, then 
diluted with diethyl ether and filtered to give 11f (0.12 g, 97%) as a white solid, mp 230 °C 
(decomp.); IR νmax 3220, 2972, 1671, 1650 1589 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38-
7.14 (10H, m) 6.21 (1H, q, J= 7.2 Hz) 4.33 (1H, dd, J= 6.9, 1.3 Hz) 3.67 (3H, s) 2.64 (1H, dd, 
J= 15.7, 6.9 Hz) 2.15 (1H, dd, J= 15.7, 1.3 Hz) 1.24 (3H, d, J= 7.2 Hz); 13C NMR (500 MHz, 
CDCl3) δ 186.6, 171.8, 170.6, 144.1, 143.9, 129.5, 129.2, 128.3, 128.1, 127.9, 127.7, 97.5, 
53.6, 51.4, 50.5, 44.9, 17.0. 
(1S,6R)-1-(α-Methylbenzyl)-3-methoxycarbonyl-6-(E)-propenylpiperidine-2,4-dione 
sodium salt (11l). Sodium methoxide in methanol (2.14 M, 2.3 mL, 5.0 mmol) was added to 
a stirred solution of diester 10l (1.58 g, 4.6 mmol) in methanol (6 mL) at 20 °C, under 
nitrogen. The mixture was then heated under reflux for 1 h. After allowing to cool to 20 °C, 
the mixture was diluted with diethyl ether and filtered to give 11l (1.46 g, 95%) as a white 
solid, mp 203-207 °C; IR νmax 3064, 2974, 1660 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35-
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7.22 (5H, m) 6.04 (1H, q, J= 7.2 Hz) 5.66 (1H, m) 5.53 (1H, m) 3.66 (3H, s) 3.60 (1H, m) 
2.33 (1H, dd, J= 15.7, 6.2 Hz) 2.18 (1H, dd, J= 15.7, 2.4 Hz) 1.61 (3H, d, J= 6.2 Hz) 1.49 
(3H, d, J= 7.2 Hz); 13C NMR (500 MHz, CDCl3) δ 188.1, 170.8, 170.7, 144.1, 132.7, 129.4, 
128.2, 128.2, 127.3, 96.4, 51.8, 51.4, 50.4, 43.4, 17.8, 17.3. HRMS C18H21NO4Na calcd. 
338.1368, found 338.1360. 
(1S,6S)-1-(α-Methylbenzyl)-6-methylpiperidine-2,4-dione (12a). Following general 
procedure C, reaction of diester 10a (0.23 g, 0.70 mmol), and sodium methoxide in methanol 
(2.0 M, 0.70 mL, 1.4 mmol) in methanol (5 mL) gave 12a (0.16 g, 97%) as a pale yellow oil, 
[α]D21 = -198.1 (c 3.09, CHCl3); IR νmax 2975, 1730, 1642 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.36-7.25 (5H, m) 6.10 (1H, q, J= 6.9 Hz) 3.55 (1H, m) 3.41-3.29 (2H, m) 2.24 (1H, dd, J= 
16.5, 8.6 Hz) 2.17 (1H, dd, J= 16.5, 5.0 Hz) 1.59 (3H, d, J= 6.9 Hz) 1.25 (3H, d, J= 6.7 Hz); 
13C NMR (500 MHz, CDCl3) δ 204.6, 166.2, 140.0, 128.8, 128.1, 127.2, 50.9, 47.4, 46.5, 
45.1, 22.7, 16.9; m/z (CI, %) 232 ([M+H]+, 100) 105 (C8H9+, 35). HRMS C14H18NO2 calcd. 
232.1338, found 232.1334. 
(1S,6R)-1-(α-Methylbenzyl)-6-phenylpiperidine-2,4-dione (12f). The piperidine-2,4-dione 
sodium salt 11f (0.10 g, 0.28 mmol) was added to hydrochloric acid (1.3M, 5 mL). The 
mixture was heated under reflux for 1 h, then allowed to cool to 20 °C and extracted with 
dichloromethane (2 x 5 mL). The combined organic layers were dried (MgSO4) and 
evaporated, and the residue was purified by flash chromatography (1:1 ethyl acetate:hexane) 
to give 12f (69 mg, 85%) as pale yellow solid, mp 104-107 °C; [α]D21 = +103.4 (c 2.95, 
CHCl3); IR νmax 2923, 1730, 1648 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.39-7.11 (10H, m) 
6.31 (1H, q, J= 7.2 Hz) 4.65 (1H, dd, J= 6.1, 2.2 Hz) 3.39 (2H, s) 2.68 (1H, dd, J= 16.4, 2.2 
Hz) 2.51 (1H, dd, J= 16.4, 6.1 Hz) 1.35 (3H, d, J= 7.2 Hz); 13C NMR (500 MHz, CDCl3) δ 
203.2, 167.4, 140.1, 140.0, 129.2, 128.9, 128.1, 128.0, 127.5, 125.7, 53.0, 51.6, 48.8, 47.9, 
16.4; m/z (EI, %) 293 ([M+H]+, 100) 105 (C8H9+, 35) 77 (C6H5+, 10). HRMS C19H19NO2 calcd. 
293.1416, found 293.1413. 
 (1S,6R)-1-(α-Methylbenzyl)-6-(pyridin-3-yl)piperidine-2,4-dione (12g). Following general 
procedure C, reaction of diester 10g (0.25 g, 0.65 mmol), and sodium methoxide in methanol 
(2.0 M, 0.65 mL, 1.30 mmol) in methanol (3 mL) gave 12g (0.19 g, 99%) as a brown oil, 
[α]D25 = -84.7 (c 1.00, CHCl3); IR νmax 2977, 1730, 1642 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.57 (1H, d, J= 4.5 Hz) 8.48 (1H, s) 7.65 (1H, m) 7.53-7.26 (6H, m) 6.31 (1H, q, J= 7.2 Hz) 
4.66 (1H, dd, J= 6.0, 1.8 Hz) 3.46 (1H, d, J= 20.6 Hz) 3.35 (1H, d, J= 20.6 Hz) 2.66 (1H, dd, 
J= 16.4, 1.8 Hz) 2.56 (1H, dd, J= 16.4, 6.0 Hz) 1.34 (3H, d, J= 7.2 Hz); 13C NMR (500 MHz, 
CDCl3) δ 202.1, 167.1, 149.6, 147.6, 139.5, 135.7, 133.2, 132.2, 129.1, 128.6, 128.3, 127.4, 
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123.8, 51.6, 51.1, 48.6, 47.7, 16.6; m/z (EI, %) 294 (M+, 15). HRMS C18H18N2O2 calcd. 
294.1368, found 294.1366. 
 (1S,6R)-1-(α-Methylbenzyl)-6-isopropylpiperidine-2,4-dione (12j). Following general 
procedure C, reaction of diester 10j (0.15 g, 0.47 mmol) and sodium methoxide in methanol 
(2.0 M, 0.50 mL, 1.0 mmol) in methanol (3 mL) afforded 12j (0.12 g, 95%) as a pale yellow 
oil, [α]D21 = -177.9 (c 1.31, CHCl3); IR νmax 2968, 1726, 1644  cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.37-7.26 (5H, m) 6.07 (1H, q, J= 7.1 Hz) 3.42 (1H, d, J= 21.3 Hz) 3.20 (1H, d, J= 
21.3 Hz) 3.16 (1H, m) 2.52 (1H, dd, J= 16.7, 5.0 Hz) 2.02-1.96 (2H, m) 1.65 (3H, d, J= 7.1 
Hz) 0.90 (3H, d, J= 6.9 Hz) 0.84 (3H, d, J= 6.9 Hz); 13C NMR (500 MHz, CDCl3) δ 208.2, 
170.2, 142.5, 131.5, 130.7, 130.2, 58.3, 55.4, 50.1, 43.7, 35.9 , 22.9, 20.4, 20.2; m/z (EI+) 259 
(M+, 100) 216 ([M-C3H7]+, 99) 105 (C8H9+, 75) 77 (C6H5+, 40). HRMS C16H21NO2 calcd. 
259.1572, found 259.1575. 
(1S,6R)-1-(α-Methylbenzyl)-6-cyclohexylpiperidine-2,4-dione (12k). Following general 
procedure C, reaction of diester 10k (0.22 g, 0.57 mmol) and sodium methoxide in methanol 
(2.0 M, 0.6 mL, 1.2 mmol) in methanol (3 mL) gave 12k (0.13 g, 76%) as a colourless oil, 
[α]D25 = -133.1 (c 3.40, CHCl3); IR νmax 2926, 1726, 1640 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.46-7.25 (5H, m) 6.03 (1H, q, J= 7.2 Hz) 3.38 (1H, d, J= 21.2 Hz) 3.26 (1H, d, J= 21.2 Hz) 
3.13 (1H, m) 2.49 (1H, dd, J= 16.7, 3.6 Hz) 1.95 (1H, dd, J= 16.7, 6.5 Hz) 1.74 (2H, m) 1.61 
(3H, d, J= 7.2 Hz) 1.59-1.47 (3H, m) 1.14-0.80 (6H, m); 13C NMR (500 MHz, CDCl3) δ 
205.6, 169.5, 139.9, 128.8, 128.0, 127.5, 55.2, 52.8, 47.7, 43.6, 41.7, 30.7, 28.6, 26.6, 26.4, 
26.0, 17.6 ; m/z (CI, %) 300 ([M+H]+, 100). HRMS C19H26NO2 calcd. 300.1964, found 
300.1953. 
(1S,6R)-1-(α-Methylbenzyl)-6-(E)-propenylpiperidine-2,4-dione (12l). The piperidine-2,4-
dione sodium salt 11l (1.0 g, 2.96 mmol) was added to hydrochloric acid (1.3M, 30 mL). The 
mixture was heated under reflux for 1 h, then allowed to cool to 20 °C and extracted with 
dichloromethane (2 x 30 mL). The combined organic layers were dried (MgSO4) and 
evaporated to give 12l (0.56 g, 74%) as a pale yellow oil, [α]D21 = -203.8 (c 2.08, CHCl3); IR 
νmax 3060, 2938, 1726, 1650 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.52-7.26 (5H, m) 6.14 (1H, 
q, J= 7.2 Hz) 5.55 (1H, ddq, J= 18.0, 6.2, 1.4 Hz) 5.41 (1H, dq, J= 18.0, 1.7 Hz) 3.92 (1H, m) 
3.41-3.24 (2H, m) 2.42 (1H, dd, J= 17.0, 2.1 Hz) 2.16 (1H, dd, J= 17.0, 5.1 Hz) 1.68 (3H, dd, 
J= 6.2, 1.7 Hz) 1.54 (3H, d, J= 7.2 Hz); 13C NMR (300 MHz, CDCl3) δ 204.1, 166.6, 139.9, 
129.8, 128.7, 128.0, 127.9, 127.3, 51.1, 50.2, 48.4, 44.9, 17.7, 16.5; m/z (CI+) 257 (M+, 70) 
105 (C8H9+, 39) 77 (C6H5+, 15). HRMS C16H19NO2 calcd. 257.1416, found 257.1428. 
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(6R)-Phenylpiperidine-2,4-dione (R)-(6f). Methanesulfonic acid (0.23 mL, 3.07 mmol) was 
added to a stirred solution of piperidine-2,4-dione 12f (1.0 g, 3.41 mmol) in toluene (15 mL) 
at 20 °C, under nitrogen. The mixture was then heated under reflux for 3 h, allowed to cool to 
20 °C, evaporated, and the residue was purified by flash chromatography (9:1 ethyl 
acetate:hexane) to give (R)-6f (0.36 g, 56%) as a white solid, mp 163-166 °C (lit.38 166-168 
°C); [α]D25 = +119.1 (c 1.00, CHCl3) (lit.38 [α]D20 = +124.3 c 0.35, CHCl3); IR νmax 3185, 2899, 
1716, 1665 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.43-7.21 (5H, m) 7.13 (1H, br s) 4.89 (1H, 
m) 3.33 (2H, s) 2.85 (1H, dd, J= 16.1, 4.5 Hz) 2.73 (1H, dd, J= 16.1, 8.9 Hz); 13C NMR (500 
MHz, CDCl3) δ 202.5, 169.2, 139.4, 129.4, 128.9, 126.1, 52.9, 47.3, 47.0; m/z (EI, %) 189 
(M+, 100). HRMS C11H11NO2 calcd. 189.0790, found 189.0787. 
 (6R)-Isopropylpiperidine-2,4-dione (R)-(6j). Methanesulfonic acid (0.02 mL, 0.26 mmol) 
was added to a stirred solution of piperidine-2,4-dione 12j (76 mg, 0.29 mmol) in toluene (2 
mL) at 20 °C, under nitrogen. The mixture was heated under reflux for 3 h, then allowed to 
cool, evaporated, and the residue was purified by flash chromatography (ethyl acetate) to give 
(R)-6j (22 mg, 48%) as a pale yellow oil; [α]D21 = +30.6 (c 0.49, CHCl3), lit.37 [α]D13 = +35.3 
(c 1.00, MeOH); IR νmax 3212, 2922, 1722, 1665 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.05 
(1H, br s) 3.49 (1H, m) 3.28 (2H, s) 2.63 (1H, dd, J= 16.1, 4.4 Hz) 2.45 (1H, dd, J= 16.1, 9.1 
Hz) 1.82 (1H, m) 1.01-0.95 (6H, m); 13C NMR (500 MHz, CDCl3) δ 203.5, 170.2, 54.3, 47.2, 
41.6, 32.5, 18.2, 17.9; m/z (ES, %) 155 (M+, 50). HRMS C8H13NO2 calcd. 155.0946, found 
155.0940. 
(6R)-Cyclohexylpiperidine-2,4-dione (R)-(6k). Methanesulfonic acid (0.04 mL, 0.61 mmol) 
was added to a stirred solution of piperidine-2,4-dione 12k (0.14 g, 0.47 mmol) in toluene (3 
mL) at 20 °C, under nitrogen. The mixture was heated under reflux for 5 h, then allowed to 
cool to 20 °C, and evaporated to give an oil that was purified by flash chromatography (ethyl 
acetate) to give (R)-6k (38 mg, 42%) as yellow solid, mp 125-127 °C; [α]D21 = +14.2 (c 1.26, 
MeOH); IR νmax 3223, 2925, 1724, 1665 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.10 (1H, br s) 
3.55 (1H, m) 3.25 (2H, s) 2.61 (1H, dd, J= 16.1, 4.8 Hz) 2.50 (1H, dd, J= 16.1, 8.1 Hz) 1.80-
1.74 (3H, m) 1.70-1.69 (2H, m) 1.60 (1H, m) 1.25-1.14 (3H, m) 1.00 (2H, m); 13C NMR (500 
MHz, CDCl3) δ 203.9, 169.4, 53.6, 47.3, 42.4, 41.7, 28.8, 28.5, 26.1, 25.9 25.8; m/z (EI, %) 
195 (M+, 2) 112 ([M-C6H11]+, 100). HRMS C11H17NO2 calcd. 195.1259, found 195.1255.  
 (1S,6R)-1-(α-Methylbenzyl)-3,3-dimethyl-6-(E)-propenylpiperidine-2,4-dione (13). To 
piperidine-2,4-dione 12l (0.13 g, 0.51 mmol) in ethanol (2 mL) was added potassium 
carbonate (0.21 g, 1.52 mmol) and methyl iodide (0.1 mL, 1.52 mmol). The mixture was 
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stirred at 40 °C for 16 h then filtered. The filtrate was evaporated and the residue was 
dissolved in chloroform (5 mL) and the solution was filtered. Evaporation afforded an oil that 
was purified by flash chromatography (15:85 ethyl acetate:hexane) to give 13 (0.11 g, 76%) 
as a colourless oil, [α]D21 = -142.9 (c 0.35, CHCl3); IR νmax 2923, 1724, 1640 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.36-7.24 (5H, m) 6.07 (1H, q, J= 6.5 Hz) 5.48 (1H, m) 5.25 (1H, m) 
3.82 (1H, m) 2.65 (1H, dd, J= 13.8, 5.7 Hz) 2.30 (1H, dd, J= 13.8, 2.5 Hz) 1.63 (3H, d, J= 6.5 
Hz) 1.51 (3H, dd, J= 7.2, 1.8 Hz) 1.38 (3H, d, J= 1.9 Hz) 1.35 (3H, d, J= 1.9 Hz); 13C NMR 
(300 MHz, CDCl3) δ 209.2, 174.0, 140.5, 131.1, 128.7, 128.3, 127.7, 127.3, 52.4, 52.1, 50.6, 
44.4, 26.5, 21.7, 17.6, 16.8; m/z (EI, %) 286 (M+, 4); 105 (C8H9+, 100). HRMS C18H24NO2 
calcd. 286.1807, found 286.1803. 
  (4R,6R)-4-Hydroxy-6-phenylpiperidin-2-one (14). Zinc borohydride (2.0 mL, 1.37 M, 2.74 
mmol) was added to a stirred solution of the piperidine-2,4-dione (R)-6f (0.19 g, 0.98 mmol) 
in anhydrous dichloromethane (2 mL) at 0 °C, under nitrogen. The mixture was then stirred at 
20 °C for 20 h. Water (5 mL) was added to the mixture which was then extracted with ethyl 
acetate (2 x 10 mL). The combined organic layers were dried (MgSO4) and evaporated. The 
residue was recrystallised from isopropanol-hexane to give 14 (0.08 g, 43%) as a white solid, 
mp 206-210 °C (lit.10b 213 °C); [α]D25 = +53.3 (c 1.20, MeOH), lit.10b [α]D20 = +52.3 (c 0.88, 
MeOH); IR νmax 3269, 2896, 1648 cm-1; 1H NMR (500 MHz, CD3OD) δ 7.38-7.28 (5H, m) 
4.51 (1H, dd, J= 11.6, 4.3 Hz) 4.11 (1H, m) 2.71 (1H, ddd, J= 17.1, 5.6, 2.3 Hz) 2.33-2.26 
(2H, m) 1.62 (1H, ddd, J= 15.6, 11.6, 10.8 Hz); 13C NMR (500 MHz, CD3OD) δ 174.1, 143.5, 
129.8, 129.0, 127.4, 65.6, 56.2, 42.7, 41.4; m/z (CI, %) 192 (M+, 100). HRMS C11H14NO2 
calcd. 192.1025, found 192.1028. 
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Legends 
Figure 1. Representative oxopiperidine derivatives with biological or pharmaceutical activity. 
 
Scheme 1. Synthesis of substituted piperidine-2,4-diones and derivatives via Dieckmann cyclisations. 
Reagents and conditions: (a) NH4OAc, AcOH, PhH, reflux, 18-72 h; (b) NaBH4 (2.5 equiv.) AcOH, 20 
°C, 3 h; (c) monomethyl malonate, EDC (1 equiv.), HOBt (1.5 equiv.), (i-Pr)2NEt, CH2Cl2, 20 °C, 2 h; 
(d) NaOMe (2 equiv.), MeOH, reflux, 1 h; (e) MeCN, 1% H2O, reflux, 1 h. 
 
Scheme 2. Synthesis of β-keto esters via Weiler dialkylation. Reagents and conditions: (a) NaH (1.1 
equiv.), BuLi (1.1 equiv.), THF, MeI or EtBr  (1.1equiv.) EtOH, 20 °C, 3 h, 97% (1b), 85%, (1c); (b) 
MeI (1.0 equiv.), K2CO3 (1.5 equiv.), Me2CO, 0 °C, 2 h, 88% (1d). 
 
Scheme 3. Synthesis of 2,3-disubstituted piperidine-2,4-diones. Reagents and conditions: (a) Zn (4 
equiv.), TMSCl (12 equiv.), CH2Cl2, THF, reflux, 2 h then NaBH4 (0.55 mole equiv.) EtOH, 20 °C, 3 h, 
15%; (b) monomethyl malonate, EDC (1.0 equiv.), HOBt (1.5 equiv.), (i-Pr)2NEt, CH2Cl2, 20 °C, 2 h, 
67%; (c) NaOMe (1.3 equiv.), MeOH, reflux, 1 h, then MeCN,1% H2O, reflux, 1 h, 56%. 
 
Figure 2. Synthesis of substituted piperidine-2,4-diones and derivatives via Dieckmann cyclisations. 
 
Scheme 4. Attempted cyclisation of diester 4f. Reagents and conditions: (a) ClOCCH2CO2Me (1.5 
equiv.), (i-Pr)2NEt (4 equiv.), 0 °C, then 20 °C, 1 h, 99%; (b) NaOMe (1.3 equiv.), MeOH, reflux, 1 h, 
then MeCN, 1% H2O, reflux, 1 h. 
 
Scheme 5. Enantioselective synthesis of substituted piperidine-2,4-diones and derivatives via 
Dieckmann cyclisations (R = (S)-1-phenylethyl). Reagents and conditions: (a) BuLi (1 equiv.), THF, -
78 °C, 30 min; RCH=CHCO2Me (1 equiv.), -78 °C, 30 min; (b) (Ph3P)3RhCl (5 mol%), aq. MeCN, 
reflux, 16 h; (c) methyl 3-chloro-3-oxopropanoate (1.1 equiv.), Et3N (1.2 equiv.), 0 °C to 20 °C, 1 h; 
(d) NaOMe (1.1 equiv.), reflux 1 h, then dil. HCl; (e) 1% water in MeCN, reflux 1 h; (f) MsOH (0.9 
equiv.), toluene, reflux, 3 h. 
 
Figure 3. Enantioselective synthesis of substituted piperidine-2,4-diones and derivatives via 
Dieckmann cyclisations (R = (S)-1-phenylethyl). 
